NSEBSE
There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.Open1,139
High1,148.6
Low1,132.1
Prev. Close1,138.5
Avg. Traded Price1,141.28
Volume3,30,975
MARKET DEPTH
Total bid4.00
Total ask0.00
| Orders | Qty | Bid |
|---|
| 2 | 4 | 1138.5 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| Ask | Qty | Orders |
|---|
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
HIGH/LOW
LOW/HIGH
₹1,132.1011 hours ago
₹1,148.608 hours ago
Bandhan Small Cap Fund-Reg(G)
3Y Return+30.2%
NAV₹197.94
Bank of India Mfg & Infra Fund-Reg(G)
Kotak Nifty Midcap 50 ETF
3Y Return+28.9%
NAV₹169.28
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)
Aurobindo Pharma Limited continues to be one of the world’s fastest growing Active Pharmaceutical Ingredients (API) manufacturing companies, driven by cost leadership, flexibility to produce multiple products in the same manufacturing facilities and capabilities in various therapeutic domains. Its API business has ensured the profitability and growth of its formulations business through seamless vertical integration. Its API business is supported by technologically advanced research and development infrastructure, which develops new products and plays a role in the delivery of products to the market. It has built a strong presence in key therapeutic segments such as Central nervous system (CNS), cardiovascular (CVS), anti-retroviral (ARV), anti-diabetics, gastroenterology and antibiotics. Also, it is building a diversified pipeline in high-margin specialty generic formulations segment.
